Bibliography
- Schellekens H, Dinan TG, Cryan JF. Lean mean fat reducing “ghrelin” machine: Hypothalamic ghrelin and ghrelin receptors as therapeutic targets in obesity. Neuropharmacology 2010;58:2-16
- Costantino L, Barlocco D. Ghrelin receptor modulators and their therapeutic potential. Future Med Chem 2009;1:157-77
- Esler WP, Rudolph J, Claus TH, Small-molecule ghrelin receptor antagonists improve glucose tolerance, suppress appetite, and promote weight loss. Endocrinology 2007;148:5175-85
- Serby MD, Zhao H, Szczepankiewicz BG, 2,4-Diaminopyrimidine derivatives as potent growth hormone secretagogue receptor antagonists. J Med Chem 2006;49:2568-78
- Romero A, Kirchner H, Heppner K, GOAT: the master switch fort the ghrelin system? Eur J Endocrinol 2010;163:1-8
- Yang J, Zhao TJ, Goldstein JL, Brown MS. Inhibition of ghrelin O-acyltransferase (GOAT) by octanoylated pentapeptides. Proc Natl Acad Sci USA 2008;105:10750-5
- University of Texas. US2010/0086955A1; 2010
- The Johns Hopkins University. WO2010/039461A2; 2010
- Kilk K, Mahlapuu R, Soomets U, Langel U. Analysis of in vitro toxicity of five cell-penetrating peptides by metabolic profiling. Toxicology 2009;265:87-95